dc.contributor.author | Xie, Liang | |
dc.contributor.author | Duncan, Michael B. | |
dc.contributor.author | Pahler, Jessica | |
dc.contributor.author | Sugimoto, Hikaru | |
dc.contributor.author | Martino, Margot | |
dc.contributor.author | Lively, Julie | |
dc.contributor.author | Mundel, Thomas | |
dc.contributor.author | Soubasakos, Mary | |
dc.contributor.author | Takeda, Takaaki | |
dc.contributor.author | Inoue, Masahiro | |
dc.contributor.author | Lawler, Jack | |
dc.contributor.author | Hanahan, Douglas | |
dc.contributor.author | Rubin, Kristofer | |
dc.contributor.author | Kalluri, Raghu | |
dc.contributor.author | Hynes, Richard O | |
dc.date.accessioned | 2012-02-03T17:21:37Z | |
dc.date.available | 2012-02-03T17:21:37Z | |
dc.date.issued | 2011-05 | |
dc.date.submitted | 2010-11 | |
dc.identifier.issn | 0027-8424 | |
dc.identifier.issn | 1091-6490 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/69020 | |
dc.description.abstract | Whereas the roles of proangiogenic factors in carcinogenesis are well established, those of endogenous angiogenesis inhibitors (EAIs) remain to be fully elaborated. We investigated the roles of three EAIs during de novo tumorigenesis to further test the angiogenic balance hypothesis, which suggests that blood vessel development in the tumor microenvironment can be governed by a net loss of negative regulators of angiogenesis in addition to the well-established principle of up-regulated angiogenesis inducers. In a mouse model of pancreatic neuroendocrine cancer, administration of endostatin, thrombospondin-1, and tumstatin peptides, as well as deletion of their genes, reveal neoplastic stage-specific effects on angiogenesis, tumor progression, and survival, correlating with endothelial expression of their receptors. Deletion of tumstatin and thrombospondin-1 in mice lacking the p53 tumor suppressor gene leads to increased incidence and reduced latency of angiogenic lymphomas associated with diminished overall survival. The results demonstrate that EAIs are part of a balance mechanism regulating tumor angiogenesis, serving as intrinsic microenvironmental barriers to tumorigenesis. | en_US |
dc.description.sponsorship | National Institute of Mental Health (U.S.) (DK55001) | en_US |
dc.description.sponsorship | National Institute of Mental Health (U.S.) (CA125550) | en_US |
dc.description.sponsorship | National Institute of Mental Health (U.S.) (RO1CA17007) | en_US |
dc.description.sponsorship | National Institute of Mental Health (U.S.) (U54CA126515) | en_US |
dc.description.sponsorship | National Institute of Mental Health (U.S.) (CA92644) | en_US |
dc.description.sponsorship | Champalimaud Metastasis Program | en_US |
dc.description.sponsorship | Stop and Shop Pediatric Tumor Foundation | en_US |
dc.description.sponsorship | 2007 United Negro College Fund/Merck Postdoctoral Fellow | en_US |
dc.description.sponsorship | National Cancer Institute (U.S.) (Grant 5T32CA081156-08) | en_US |
dc.description.sponsorship | Howard Hughes Medical Institute | en_US |
dc.description.sponsorship | Deutsche Forschungsgemeinschaft (DFG) (MU 2298/2-2) | en_US |
dc.description.sponsorship | National Cancer Institute (U.S.) | en_US |
dc.description.sponsorship | William K. Bowes Jr. Charitable Foundation | en_US |
dc.description.sponsorship | Japanese Society for the Promotion of Science (Grant-in-Aid for Scientific Research) | en_US |
dc.language.iso | en_US | |
dc.publisher | Proceedings of the National Academy of Sciences (PNAS) | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1073/pnas.1105041108 | en_US |
dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
dc.source | PNAS | en_US |
dc.title | Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Xie, L. et al. “Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner.” Proceedings of the National Academy of Sciences 108.24 (2011): 9939-9944. Web. 2 Feb. 2012. | en_US |
dc.contributor.department | Harvard University--MIT Division of Health Sciences and Technology | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | en_US |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
dc.contributor.approver | Hynes, Richard O. | |
dc.contributor.mitauthor | Rubin, Kristofer | |
dc.contributor.mitauthor | Hynes, Richard O. | |
dc.contributor.mitauthor | Kalluri, Raghu | |
dc.relation.journal | Proceedings of the National Academy of Sciences | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Xie, L.; Duncan, M. B.; Pahler, J.; Sugimoto, H.; Martino, M.; Lively, J.; Mundel, T.; Soubasakos, M.; Rubin, K.; Takeda, T.; Inoue, M.; Lawler, J.; Hynes, R. O.; Hanahan, D.; Kalluri, R. | en |
dc.identifier.orcid | https://orcid.org/0000-0001-7603-8396 | |
mit.license | PUBLISHER_POLICY | en_US |
mit.metadata.status | Complete | |